Login / Signup

Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma.

Qiong LiWei ZhangJiali LiJingkang XiongJia LiuTing ChenQin WenYunjing ZengLi GaoLei GaoCheng ZhangPeiyan KongXiangui PengYao LiuXi ZhangJun Rao
Published in: Biomarker research (2020)
This study is registered with chictr.org (ChiCTR1800014813, registered 7 February, 2018-Retrospectively registered).
Keyphrases
  • circulating tumor
  • prognostic factors
  • cell free
  • circulating tumor cells
  • single molecule
  • risk assessment